Relationship between blood pressure variability and serum dehydroepiandrosterone sulfate levels

American Journal of Hypertension

Volumn 11, Issue 5, 1998, Pages 532-538

  Barna, István ^a,b   Fehér, Tibor ^a   De Châtel, Rudolf ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NONE   (Hungary)

Author keywords

Ambulatory blood pressure monitoring; Dehydroepiandrosterone sulfate; Diurnal blood pressure variability; Hypertension

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PRASTERONE;

ANDROGEN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGING; BLOOD PRESSURE; CIRCADIAN RHYTHM; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 0031839481     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00408-1     Document Type: Article

References (26)

1. Barna I: Clinical Hypertension. Springer Press, Budapest, 1995, pp 28-31.
2. Mancia G, Zanchetti A: Ambulatory blood pressure monitoring in hypertension. Clin Exp Hypertension 1993;15:1099-1108.
3. Pickering TG: The clinical significance of diurnal blood pressure variations: dippers and non-dippers. Circulation 1990;81:700-702.
4. Staessen JA, O'Brien ET, Atkins M, et al: Ambulatory blood pressure in normotensive compared to hypertensive patients. J Hypertens 1993;11:1289-1297.
5. Belanger AB, Carridas A, Dupont L, et al: Changes in serum concentration of conjugated and unconjugated steroids in 40 to 80 year old men. J Clin Endocrinol Metab 1994;79:1086-1090.
6. Oreintreich NJL, Brind RL, Rizer J, et al: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration during adulthood. J Clin Endocrinol Metab 1984;59:551-555.
7. Rotter JIL, Wong ET, Lifrak L, et al: A genetic component of the variation of dehydroepiandrosterone sulfate. Metabolism 1985;34:731-736.
8. Barrett-Connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulphate, mortality and cardiovascular disease. N Engl J Med 1986;315: 1519-1524.
9. Lacroix A, Yano K, Reed DM: Dehydroepiandrosterone sulfate, incidence of myocardial infarction and extent of atherosclerosis in men. Circulation 1992;786:1529-1535.
10. Staessen JA, Fogard R, Lijnen P: Reference values for ambulatory blood pressure: meta-analysis. J Hypertens 1994;8(suppl):S57-S64.
11. Fehér T, Bodrogi L: A comparative study of antibodies and radioimmunoassays for the determination of unconjugated dehydroepiandrosterone and dehydroepiandrosterone sulphate, in Görög S (ed): Advances in Steroid Analysis. Academic Press, Budapest, 1988, pp 129-134.
12. Middeke M, Schrader J: Nocturnal blood pressure in normotensive subjects and those with white coat, primary and secondary hypertension. Br Med J 1994;308: 630-632.
13. Barna I, Tislér A, Kempler P, et al: The influence of chronic smoking on the diurnal rhythm of blood pressure in healthy individuals and in insulin dependent diabetic patients (in Hungarian). Magyar Belorvasi Archivum 1995;48:37-40.
14. Barna I, Földes K, Sandil A, et al: 24 hours blood pressure monitoring after kidney transplantation, (abst) (in Hungarian). Diabetologia Hungarica 1996; 1(suppl):5.
15. Mancia G, Di Rienzo M, Paratti G: Ambulatory blood pressure monitoring: use in hypertension research and clinical practice. Hypertension 1993;21:510-524.
16. Giaconi S: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989;2:259-261.
17. Barna I, Kempler P, Olajos F, et al: Altered diurnal blood pressure variability in overweight hypertensive women; its relationship with alcohol consumption (abst) Am J Hypertens 1996;9 (4, part 2): 99A.
18. Shimida K, Kawamoto A, Matsubayashi K, et al: Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990;16:692-699.
19. Barrett-Connor E, Khaw KT: Absence of an inverse relation of DHEAS with cardiovascular mortality in postmenopausal women. N Engl J Med 1987;317:711-713.
20. Oreintereich NJL, Brind RL, Vogelman H, et al: Long term longitudinal measurements of plasma DHEAS in normal men. J Clin Endocrinol Metab 1992;75:1002-1004.
21. Thomas G, Frenoy M, Legrain R, et al: Serum DHEAS levels as an individual marker. J Clin Endocrinol Metab 1994;79:1273-1276.
22. Hautanen A, Manntari M, Maninen V, et al: Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis 1994;105:191-200.
23. Fehér T, Halmy L: Dehydroepiandrosterone and dehydroepiandrosterone sulfate dynamics in obesity. Can J Biochem 1975;53:215-222.
24. Nafziger AN, Herrington DM, Bush TL: Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease. Epidemiol Rev 1991;13:267-293.
25. Beer NA, Jakubowicz DJ, Beer RM, Nestler JE: The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione but lowers serum cortisol, in insulin resistant obese and hypertensive men. J Clin Endocrinol Metab 1993;76: 1464-1469.
26. Barbagallo M, Shan J, Pang PKT, Resnick LM: Effects of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility. Hypertension 1995;26 (6, part 2):1065-1069.